BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 23623915)

  • 21. No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial.
    Thyregod HG; Steinbrüchel DA; Ihlemann N; Ngo TA; Nissen H; Kjeldsen BJ; Chang Y; Hansen PB; Olsen PS; Søndergaard L
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):721-728. PubMed ID: 27005980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
    J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic performance and outcome of percutaneous versus surgical stentless bioprostheses for aortic stenosis with anticipated patient-prosthesis mismatch.
    Finkelstein A; Schwartz AL; Uretzky G; Banai S; Keren G; Kramer A; Topilsky Y
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1892-9. PubMed ID: 23993320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Valve Size on Prosthesis-Patient Mismatch and Aortic Valve Gradient After Transcatheter versus Surgical Aortic Valve Replacement.
    Aalaei-Andabili SH; Lee TC; Waheed N; Bavry AA; Petersen JW; Wayangankar S; Arnaoutakis GJ; David Anderson R; Beaver TM
    Innovations (Phila); 2019 Jun; 14(3):243-250. PubMed ID: 31074313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization and 1-Year Mortality for Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement in New York Patients With Aortic Stenosis: 2011 to 2012.
    Hannan EL; Samadashvili Z; Stamato NJ; Lahey SJ; Wechsler A; Jordan D; Sundt TM; Gold JP; Ruiz CE; Ashraf MH; Smith CR
    JACC Cardiovasc Interv; 2016 Mar; 9(6):578-85. PubMed ID: 27013157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
    Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
    J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial.
    Dewey TM; Bowers B; Thourani VH; Babaliaros V; Smith CR; Leon MB; Svensson LG; Tuzcu EM; Miller DC; Teirstein PS; Tyner J; Brown DL; Fontana GP; Makkar RR; Williams MR; George I; Kirtane AJ; Bavaria JE; Mack MJ
    Ann Thorac Surg; 2013 Dec; 96(6):2083-9. PubMed ID: 23968764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials.
    Summers MR; Leon MB; Smith CR; Kodali SK; Thourani VH; Herrmann HC; Makkar RR; Pibarot P; Webb JG; Leipsic J; Alu MC; Crowley A; Hahn RT; Kapadia SR; Tuzcu EM; Svensson L; Cremer PC; Jaber WA
    Circulation; 2019 Dec; 140(24):1984-1994. PubMed ID: 31690104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement.
    Kim SJ; Samad Z; Bloomfield GS; Douglas PS
    Am Heart J; 2014 Aug; 168(2):150-9.e1-7. PubMed ID: 25066553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
    Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB
    J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial.
    Daubert MA; Weissman NJ; Hahn RT; Pibarot P; Parvataneni R; Mack MJ; Svensson LG; Gopal D; Kapadia S; Siegel RJ; Kodali SK; Szeto WY; Makkar R; Leon MB; Douglas PS
    JACC Cardiovasc Imaging; 2016 Dec; ():. PubMed ID: 28017714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
    Yesiltas MA; Haberal İ; Kuserli Y; Yildiz A; Koyuncu AO; Özsoy SD
    Heart Surg Forum; 2020 Apr; 23(2):E212-E220. PubMed ID: 32364917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.